CDC Chooses Five Laboratories For Pathogen Genomics Network

The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.

• Source: Shutterstock

The Centers for Disease Control and Prevention (CDC) has named five state laboratories to the Pathogen Genomics Centers of Excellence (PGCoE) Network, a consortium of labs with the goal of piloting new technology and preparing for future pandemics and infectious diseases.

Who will the centers work with?
  • Georgia Department of Public Health: University of Georgia, Georgia Tech Research Institute, Emory University, Augusta University, Georgia State University, and the University of Texas Health Science Center at Houston.

The five labs chosen were the Georgia Department of Public Health, the Minnesota Department of Health, the Massachusetts Department of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

BCI Maker INBRAIN Inks Deal With Microsoft To Explore Agentic AI Use For Monitoring Patients

 
• By 

INBRAIN teamed up with Microsoft to apply agentic AI to analyze real-time brain data and eventually recommend programming like a “mini-neurologist,” said CEO Carolina Aguilar. It also seeks to enable scalable deployment of INBRAIN’s graphene-based technology and potential joined research.

Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change

 

The prosthetics market is evolving due to an increase in amputees from war and disease. Unhindr has developed a novel prostetic liner that can reduce the risk of further injury, while Esper is crafting advanced hand implants for Ukraine's front-line soldiers.

Synchron Secures $200M Series D, Plans New Brain Interface With ‘Potentially More Applications’

 
• By 

Synchron raised $200m in series D funding to support pivotal trials in 2026 as well as commercialization of its Stentrode BCI. It also announced plans for a next-gen high-channel whole-brain interface and a new engineering hub in San Diego.

Makary And Oz Tout Successes At Their Respective Agencies, Say They Are Breaking Down Walls

 

Nearly one year into leading their agencies, US FDA Commission Marty Makary and CMS Administrator Mehmet Oz took to the stage together at the Milken Institute’s Future of Health Summit 2025 to highlight what they see as progress and lay out plans for the road ahead.

More from Business

Deals Shaping The Medtech And Diagnostics Industries, October 2025

 
• By 

An interactive look at medtech and diagnostics deals made during October 2025. Data courtesy of Biomedtracker.

Synchron Secures $200M Series D, Plans New Brain Interface With ‘Potentially More Applications’

 
• By 

Synchron raised $200m in series D funding to support pivotal trials in 2026 as well as commercialization of its Stentrode BCI. It also announced plans for a next-gen high-channel whole-brain interface and a new engineering hub in San Diego.

Makary And Oz Tout Successes At Their Respective Agencies, Say They Are Breaking Down Walls

 

Nearly one year into leading their agencies, US FDA Commission Marty Makary and CMS Administrator Mehmet Oz took to the stage together at the Milken Institute’s Future of Health Summit 2025 to highlight what they see as progress and lay out plans for the road ahead.